Delivery Order SPE2DB22D2206-SPE2DB24FGE14
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,963.18 firm fixed-price delivery order contract is for the supply of Talvey 40 mg/ml vials. The contract has an ultimate completion date of April 30, 2025 and is not designated with a set-aside requirement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,145.03 firm fixed-price delivery order contract is for the supply of "TALVEY 40 MG/ML VIALML" medical products, with a performance period through June 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,926.36 firm fixed price delivery order contract is for the supply of "TALVEY 40 MG/ML VIALML" medical products. The contract has an ultimate completion date of March 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,496.07 firm fixed-price delivery order is for the supply of 4566120553 TALVEY 3 MG/1.5 ML VIAL 1.5ML, with a completion date of November 6, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,963.18 Firm Fixed Price delivery order contract covers the supply of TALVEY 40 MG/ML VIALML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award, valued at $26,860.04, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of TALVEY 40 MG/ML VIALML, a pharmaceutical product, to support the medical supply needs of federal agencies and healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,496.07, is for the delivery of Talvey 3 mg/1.5 ml vials. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999,...
- This federal contract award is for the delivery of Talvey 40 mg/ml vial medication to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, Corporate Office division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $42,973.28 delivery order contract is a firm fixed-price arrangement with a completion date of September 25, 2024. The contract does not have a set-aside designation. Amerisourcebergen is a key supplier of...
- This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUS89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,704.14 firm-fixed-price delivery order contract is for the supply of TALVEY 40 MG/ML VIALML, a medical product. The contract has an ultimate completion date of March 20, 2025 and was awarded on February 27, 2025. It is not designated as a set-aside contract....
- This award is for a Firm Fixed Price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is with the Defense Logistics Agency (DLA) and is valued at $26,860.04. It is for the supply of the pharmaceutical product "TALVEY 40 MG/ML VIALML" with a period of performance through May 28, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGE14Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $27,225.24 firm fixed price delivery order is for the supply of Talvey 40 mg/ml vials, a pharmaceutical product. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the U.S. Department of Defense. No set-aside designations have been used for these contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.2k | 3/19/24 |